期刊文献+

兰索拉唑治疗上消化道溃疡的疗效观察 被引量:16

Clinical Observation of the Treating Effect of Lansoprazole on Gastroduodenal Ucer
下载PDF
导出
摘要 目的观察兰索拉唑三联疗法对上消化道溃疡的临床疗效。方法将130例患者随机分为兰索拉唑治疗组(65例)、对照组(65例)。治疗组采用兰索拉唑30mg+左氧氟沙星0.2g+克拉霉素0.5g口服治疗,对照组采用法莫替丁20mg+左氧氟沙星0.2g+克拉霉素0.5g口服治疗,在治疗结束后观察临床症状改善情况并检测对Hp的根除情况。结果治疗组的总有效率及Hp根除率分别为93.85%和86.15%,明显的高于对照组81.54%和72.31%,两组相比均具有明显的统计学差异(P<0.05)。结论兰索拉唑三联疗法对上消化道溃疡具有较好的临床疗效,值得临床上推广使用。 Objective To explore the therapeutical effect of lansoprazole on gastroduodenal ucer. Methods 130 patients with gastroduodenal ucer were divided into treatment group (65 cases)and control group (65 cases) randomly. Patients in the treatment group were treated with lansoprazole + levofloxacin + clarithromycin. Patients in the control group were treated with famotidine + levofloxacin + clarithromycin. The symptoms and healing state were observed during and after treatment. Results The total curative rate and eradication rate of the treatment group were obviously better than that of the control group,and compared with the control group both of them have statistical difference (P〈0.05). Conclusion The application of lansoprazole has a good clinical therapeutical effect on gastroduodenal ucer,and the it is worthy of being used wide range.
作者 王晨曦
出处 《中国现代医生》 2011年第1期155-156,共2页 China Modern Doctor
关键词 兰索拉唑 幽门螺旋杆菌 上消化道溃疡 Lansoprazole Helicobacter pylori Gastroduodenal ueer
  • 相关文献

参考文献9

二级参考文献36

  • 1余俐,彭杰青,邬全会,暴菊英.慢性活动性胃炎的诊断标准及其与Hp、GH关系[J].中国误诊学杂志,2004,4(2):161-163. 被引量:26
  • 2王鋆,张钧.药物经济学成本-效果分析[J].药学实践杂志,1995,13(4):193-197. 被引量:462
  • 3Watanabe Y, Aoyama N, Shirasaka D, et al. Levofloxacin based triple therapy as a second-line treatment after failure of helicobacter pylori eradication with standard triple therapy [ J ]. Dig Liver Dis, 2003,35(10) :711-715.
  • 4Malfertheiner P, Megraud F, O' Morain C, et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2- 2000 Consensus Report [J]. Aliment Pharmacol Ther, 2002, 16 (2) :167-180.
  • 5Graham DY. Antibiotic resistance in Helicobacter pylori: implications for therapy [J]. Gastroenterology, 1998,115(5) :1272-1277.
  • 6Ling TK, Cheng AF, Sung JJ, et al. An increase in Helicobacter pylori strains resistant to metronidasole : a five-year study [ J]. Helicobacter, 1996,1 ( 1 ) :57-61.
  • 7Cammarota G, Cianci R, Cannissaro O, et al. Efficacy of two one- week rabeprasole/levofloxacin-based triple therapies for Helicobacter pylori infection [ J ]. Aliment Pharmacol Ther, 2000, 14 ( 10 ) : 1339-1343.
  • 8Di Caro S, Zocco MA, Cremonini F, et al. Levofloxacin based regimens for the eradication of Helicobacter pylori [ J]. Eur J Gastroenterol Hepatol, 2002,14 ( 12 ) : 1309 -1312.
  • 9Peril F, Fests V, Merla A, et al. Randomised study of different ' second-line' therapies for Helicobaeter pylori infection after failure of the standard ' Masstricht triple therapy' [ J ]. Aliment Pharmaeol Ther, 2003,18(8) :815-820.
  • 10路又可,王桂玲,王琳,朱人敏,王年吉.南京市区消化科医护人员中幽门螺杆菌感染的流行病学调查[J].中华流行病学杂志,1997,18(2):70-72. 被引量:5

共引文献580

同被引文献88

引证文献16

二级引证文献154

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部